Nightingale Health

Nightingale Health is a Finland-based biotechnology and healthcare company, founded in 2013, with a mission to make preventative health accessible to all. Their advanced blood analysis technology and extensive health event data enable comprehensive disease risk predictions, leading to informed personal health decisions. The recent Venture Round investment on 31 January 2020 was supported by LongevityTech.fund and Yrjö Närhinen. With a team of 90 professionals from diverse backgrounds, including business, marketing, computational medicine, data science, healthcare, and design, Nightingale Health aims to prioritize proactive health management over reactive illness treatment, driving impactful advancements in the health industry.